...
首页> 外文期刊>Journal of Inorganic Biochemistry: An Interdisciplinary Journal >Behavior of the potential antitumor (VO)-O-IV complexes formed by flavonoid ligands. 2. Characterization of sulfonate derivatives of quercetin and morin, interaction with the bioligands of the plasma and preliminary biotransformation studies
【24h】

Behavior of the potential antitumor (VO)-O-IV complexes formed by flavonoid ligands. 2. Characterization of sulfonate derivatives of quercetin and morin, interaction with the bioligands of the plasma and preliminary biotransformation studies

机译:类黄酮配体形成的潜在抗肿瘤(VO)-O-IV络合物的行为。 2.槲皮素和香豆素的磺酸盐衍生物的表征,与血浆生物配体的相互作用以及初步的生物转化研究

获取原文
获取原文并翻译 | 示例
           

摘要

The biotransformation in the plasma and red blood cells of two potential antitumor (VO)-O-IV complexes formed by flavonoid ligands (quercetin or que and morin or mor) and their sulfonic derivatives (quercetin-5'-sulfonic acid or ques(S) and morin-5'-sulfonic acid or mor(S)) was studied by spectroscopic (EPR, Electron Paramagnetic Resonance) and computational (DFT, Density Functional Theory) methods. Que and que(S) form with (VO)-O-IV stable complexes, and in the systems with apo-transferrin (apo-hTf) and albumin (HSA) VO(que)(2) and VO(que(S))(2) remain unchanged. VO(mor)(2) and VO(mors)(2) undergo displacement reactions to give the partial formation of (VO)(x)(HSA) and (VO)(apo-hTf)/(VO)(2)(apo-hTf); moreover, mor(S) forms with apo-transferrin and albumin mixed species VO mor(S) apo-hTf and VO mor(S)-HSA. In the systems with apo-hTf and HSA anisotropic EPR spectra at room temperature are detected in which the protein is not directly coordinated to (VO2+)-O-IV ion. This is explained assuming that the bis-chelated complexes interact strongly with the proteins through a network of hydrogen bonds with the polar groups present on the protein surface. It is suggested that this "indirect" transport of (VO)-O-IV species could be common to all the species containing ligands which can interact with the blood proteins. Uptake experiments by red blood cells were also carried out, using vanadium concentration of 5.0 x 10(-4) M and incubation time in the range 0-160 min. VO(que)(2)/VO(que(S))(2) and VO(mor)(2)/VO(mor(S))(2) cross the erythrocytes membrane and in the cytosol VO(que)(2)/VO(ques)(2) do not transform, whereas VO(mor)(2)/VO(mor(S))(2) give the partial formation of mixed species with hemoglobin (Hb) and other (VO)-O-IV complexes. (C) 2015 Elsevier Inc All rights reserved.
机译:黄酮类配体(槲皮素或que和morin或mor)及其磺酸衍生物(槲皮素-5'-磺酸或ques(S)形成的两种潜在的抗肿瘤(VO)-O-IV复合物在血浆和红细胞中的生物转化)和morin-5'-磺酸或mor(S))通过光谱法(EPR,电子顺磁共振)和计算法(DFT,密度泛函理论)研究。 Que和que(S)与(VO)-O-IV稳定络合物形成,并且在具有脱辅基转铁蛋白(apo-hTf)和白蛋白(HSA)的系统中VO(que)(2)和VO(que(S) )(2)保持不变。 VO(mor)(2)和VO(mors)(2)发生置换反应以部分生成(VO)(x)(HSA)和(VO)(apo-hTf)/(VO)(2)( apo-hTf);此外,mor(s)与脱铁运铁蛋白和白蛋白混合物种VO mor(S)apo-hTf和VO mor(S)-HSA混合形成。在具有apo-hTf和HSA的系统中,检测到室温下的EPR各向异性光谱,其中蛋白质未直接与(VO2 +)-O-IV离子配位。假设双螯合的复合物通过氢键网络与蛋白质表面上存在的极性基团与蛋白质强烈相互作用,可以解释这一点。有人提出,(VO)-O-IV物种的这种“间接”运输可能是所有含有能够与血液蛋白相互作用的配体的物种所共有的。还进行了红细胞的吸收实验,使用的钒浓度为5.0 x 10(-4)M,孵育时间为0-160分钟。 VO(que)(2)/ VO(que(S))(2)和VO(mor)(2)/ VO(mor(S))(2)穿过红细胞膜并在胞质溶胶中VO(que)( 2)/ VO(ques)(2)不变换,而VO(mor)(2)/ VO(mor(S))(2)可以部分形成与血红蛋白(Hb)和其他(VO)混合的物种-O-IV配合物。 (C)2015 Elsevier Inc保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号